BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 29428159)

  • 1. Cerebral protection devices during transcatheter aortic valve implantation.
    Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
    Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ndunda PM; Vindhyal MR; Muutu TM; Fanari Z
    Cardiovasc Revasc Med; 2020 Jun; 21(6):717-722. PubMed ID: 31175048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Protection During Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta-Analysis.
    Testa L; Latib A; Casenghi M; Gorla R; Colombo A; Bedogni F
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art.
    Deveci OS; Okutucu S; Fatihoglu SG; Oto A
    Acta Cardiol; 2022 May; 77(3):196-203. PubMed ID: 33827380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement.
    Rossow CF; McCabe JM
    Curr Cardiol Rep; 2016 Feb; 18(2):16. PubMed ID: 26768742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral Embolic Protection and Stroke-Related Mortality Following Transcatheter Aortic Valve Replacement.
    Isogai T; Bansal A; Vanguru HR; Agrawal A; Shekhar S; Puri R; Reed GW; Krishnaswamy A; Uchino K; Kapadia SR
    JACC Cardiovasc Interv; 2022 Mar; 15(5):569-571. PubMed ID: 35272784
    [No Abstract]   [Full Text] [Related]  

  • 10. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
    Onsea K; Agostoni P; Samim M; Voskuil M; Kluin J; Budde R; Hendrikse J; Ramjankhan F; van Klarenbosch J; Doesburg P; Sieswerda G; Stella P
    EuroIntervention; 2012 May; 8(1):51-6. PubMed ID: 22580248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral protection devices for transcatheter aortic valve replacement.
    Jobanputra Y; Jones BM; Mohananey D; Fatima B; Kandregula K; Kapadia SR
    Expert Rev Med Devices; 2017 Jul; 14(7):529-543. PubMed ID: 28658982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the future role of cerebral embolic protection in transcatheter aortic valve implantation?
    Sondergaard L; Mylotte D; Capodanno D
    EuroIntervention; 2022 Oct; 18(8):e617-e619. PubMed ID: 36205735
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
    Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
    EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: A clinical end-points meta-analysis.
    Mohananey D; Sankaramangalam K; Kumar A; Jobanputra Y; Villablanca P; Krishnaswamy A; Mick S; Svensson LG; Tuzcu EM; Kapadia SR
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):785-791. PubMed ID: 29550047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study.
    Kawakami R; Gada H; Rinaldi MJ; Nazif TM; Leon MB; Kapadia S; Krishnaswamy A; Sakamoto A; Sato Y; Mori M; Kawai K; Cornelissen A; Park JE; Ghosh SKB; Abebe BG; Romero M; Virmani R; Finn AV
    Circ Cardiovasc Interv; 2022 Apr; 15(4):e011358. PubMed ID: 35272475
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI).
    Doerner J; Kupczyk PA; Wilsing M; Luetkens JA; Storm K; Fimmers R; Hickethier T; Eichhorn L; Naehle CP; Schild HH; Werner N; Nickenig G; Ghanem A
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):774-782. PubMed ID: 28547872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
    Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
    EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
    Pagnesi M; Martino EA; Chiarito M; Mangieri A; Jabbour RJ; Van Mieghem NM; Kodali SK; Godino C; Landoni G; Colombo A; Latib A
    Int J Cardiol; 2016 Oct; 221():97-106. PubMed ID: 27400304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.